Evidence map›Paper›PMID 30808219›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor.

Takeshi Matsumoto, Hideo Wada, Kohshi Ohishi, Yoshiki Yamashita, Makoto Ikejiri, Naoyuki Katayama

Abstract readLetter
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Update on the Clot Waveform Analysis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Takeshi Matsumoto1 Blood Transfusion Service and Cell Therapy, Mie University Hospital, Tsu, Japan.
Hideo Wada2 Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Mie, Japan.ORCID https://orcid.org/0000-0001-9021-8633
Kohshi Ohishi2 Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Mie, Japan.
Yoshiki Yamashita3 Department of Hematology and Oncology, Tsu, Mie, Japan.
Makoto Ikejiri4 Central Laboratory, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
Naoyuki Katayama3 Department of Hematology and Oncology, Tsu, Mie, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hemophilia AHemostaticsHumansPartial Thromboplastin TimeHemostaticsAPTThemophiliainhibitorlupus anticoagulantwaveform

Identifiers

PMID30808219
PMCPMC6714993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.